Proprietary Portfolio
Orphan diseases / critical conditions with high unmet need
Mix of Marketed, Clinical, and PreclinicalActive
Key Facts
Indication
Orphan diseases / critical conditions with high unmet need
Phase
Mix of Marketed, Clinical, and Preclinical
Status
Active
Company
About Adienne Pharma and Biotech
Adienne is a private, integrated biopharma group founded in 2008, specializing in orphan drugs and biosimilars. The company operates with a dual headquarters structure in Switzerland and Italy, leveraging its manufacturing capabilities to develop therapies for niche, high-need therapeutic areas. Its pipeline includes marketed, clinical, and preclinical assets, positioning it in the commercial stage with a focus on rare diseases.
View full company profile